|
APAF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.75230000299243E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.90210000159541E-08 |
| Normal-vs-Stage2 |
3.562900E-04 |
| Normal-vs-Stage3 |
6.23909999999395E-05 |
| Normal-vs-Stage4 |
5.36509999982115E-07 |
| Stage1-vs-Stage2 |
9.611400E-01 |
| Stage1-vs-Stage3 |
2.939000E-01 |
| Stage1-vs-Stage4 |
9.340400E-01 |
| Stage2-vs-Stage3 |
5.277200E-01 |
| Stage2-vs-Stage4 |
9.925000E-01 |
| Stage3-vs-Stage4 |
4.257600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.7584000012767E-08 |
| Normal-vs-AfricanAmerican |
3.504000E-03 |
| Normal-vs-Asian |
2.1914999999928E-05 |
| Caucasian-vs-AfricanAmerican |
1.499040E-01 |
| Caucasian-vs-Asian |
3.448000E-02 |
| AfricanAmerican-vs-Asian |
9.035500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.83250000121527E-08 |
| Normal-vs-Female |
6.88760000144839E-08 |
| Male-vs-Female |
9.735400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.933820E-02 |
| Normal-vs-Age(41-60Yrs) |
3.45980000204804E-09 |
| Normal-vs-Age(61-80Yrs) |
5.46799999945335E-07 |
| Normal-vs-Age(81-100Yrs) |
6.835800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.994160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.001600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.940400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.739200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.552100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.052000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.03380000000086E-05 |
| Normal-vs-Grade 2 |
8.58810000892163E-09 |
| Normal-vs-Grade 3 |
2.79700000049843E-07 |
| Normal-vs-Grade 4 |
9.57699999999395E-05 |
| Grade 1-vs-Grade 2 |
2.503400E-01 |
| Grade 1-vs-Grade 3 |
4.337500E-02 |
| Grade 1-vs-Grade 4 |
5.296500E-02 |
| Grade 2-vs-Grade 3 |
1.671010E-01 |
| Grade 2-vs-Grade 4 |
2.241000E-01 |
| Grade 3-vs-Grade 4 |
8.386800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.42950001519915E-09 |
| Normal-vs-ccB subtype |
9.00249999991054E-07 |
| ccA subtype-vs-ccB subtype |
2.523200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.84849999751435E-08 |
| Normal-vs-N1 |
1.935490E-03 |
| N0-vs-N1 |
7.964600E-01 |
|
|
